European Achondroplasia Forum Practical Considerations for Following Adults with Achondroplasia
- PMID: 38748332
- PMCID: PMC11213767
- DOI: 10.1007/s12325-024-02880-3
European Achondroplasia Forum Practical Considerations for Following Adults with Achondroplasia
Abstract
Achondroplasia is a lifelong condition requiring lifelong management. There is consensus that infants and children with achondroplasia should be managed by a multidisciplinary team experienced in the condition. However, many people are lost to follow-up after the transition from paediatric to adult care, and there is no standardised approach for management in adults, despite the recent availability of international consensus guidelines. To address this, the European Achondroplasia Forum has developed a patient-held checklist to support adults with achondroplasia in managing their health. The checklist highlights key symptoms of spinal stenosis and obstructive sleep apnoea, both among the most frequent and potentially severe medical complications in adults with achondroplasia. The checklist acts as a framework to support individuals and their primary care provider in completing a routine review. General advice on issues such as blood pressure, pain, hearing, weight, adaptive aids, and psychosocial aspects are also included. The checklist provides key symptoms to be aware of, in addition to action points so that people can approach their primary care provider and be directed to the appropriate specialist, if needed. Additionally, the European Achondroplasia Forum offers some ideas on implementing the checklist during the transition from paediatric to adult care, thus ensuring the existing multidisciplinary team model in place during childhood can support in engaging individuals and empowering them to take responsibility for their own care as they move into adulthood.
Keywords: Achondroplasia; Adult; Assessment; Checklist; EAF; Follow-up; Sleep apnoea; Spinal stenosis; Transition.
© 2024. The Author(s).
Conflict of interest statement
Svein Fredwall, Moeenaldeen AlSayed, Tawfeg Ben Omran, Brigitte Fauroux and Christian Lampe have nothing to disclose. Silvio Boero has received payment or honoraria, support for attending meetings and/or travel from BioMarin. Valerie Cormier-Daire has received payment or honoraria, support for attending meetings and/or travel from BioMarin. Sérgio B Sousa has received payment or honoraria, support for attending meetings and/or travel and has participated in Advisory Boards for BioMarin. Encarna Guillen-Navarro has received payment or honoraria, support for attending meetings and/or travel from BioMarin. Florian Innig has received grants or contracts paid to BKMF e.V from BioMarin. Melita Irving has received grants or contracts and consulting fees from BioMarin, QED/Bridge Bio, Ascendis, Sanofi, Tyra, NovoNordisk; and payment or honoraria from BioMarin; and has participated in Advisory Boards for BioMarin and QED/BridgeBio. Philip Kunkel has received payment or honoraria, support for attending meetings and/or travel from BioMarin. Mohamad Maghnie has received consulting fees, payment or honoraria, support for attending meetings and/or travel and has participated in Advisory Boards for BioMarin. Klaus Mohnike has received consulting fees from BioMarin and NovoNordisk, payment or honoraria from Kyowa-Kirin, support for attending meetings and/or travel from BioMarin, has participated in Advisory Boards for QED and is Vice-Chair of BKMJ. Geert Mortier has received payment or honoraria and support for attending meetings and/or travel from BioMarin, and has participated in Advisory Boards for Sanofi. Zagorka Pejin has received consulting fees and payment or honoraria from Orthofix Italy and Newclip France; support for attending meetings and/or travel from Orthofix Italy, and patents planned, issued or pending with Orthofix Italy. Marco Sessa has received grants or contracts paid to AISAC OdV from BioMarin and QED.
References
MeSH terms
LinkOut - more resources
Full Text Sources
